Back to directoryHow we evaluate →

University Compounding Pharmacy

San Diego, CA·503A
Past issue, resolved·Last checked August 17, 2026.

Past issue, resolved — closeout on file (Dec 2018).

About this pharmacy

Legal entity: University Rx Specialists, Inc. dba University Compounding Pharmacyi
Facility type: 503Ai compounding pharmacy.

The four standards

01
Accredited— Confirmed (PCAB)

Holds PCABi accreditation, per the pharmacy’s own published statement.

(Method: confirmed via accreditation statement provided by the pharmacy. PCAB does not currently offer a public per-pharmacy searchable database.)

02
Regulatory record— Past issue, resolved

In 2016, FDA inspectors found CGMPi violations and production of ineligible drug products at this facility. University Compounding Pharmacy corrected it, and FDA formally confirmed the correction in 2018.

(Method: checked against FDA’s public warning-letter and closeout-letter databases.)

Source: FDA warning letter — September 2016

Source: FDA closeout letter — December 2018

03
Openly named— Confirmed

Operates under its stated legal name, not private-label branding.

04
Shipping reputation— Not yet evaluated

This standard has not yet been checked for this pharmacy.

Notes

Context
Disambiguation— Not the Troy, MI entity

A separate, unrelated pharmacy with a similar name operates in Troy, MI. This is a different business from the San Diego, CA entity evaluated here.

Frequently asked questions

Is University Compounding Pharmacy accredited?

Yes. University Compounding Pharmacy holds PCAB accreditation, per the pharmacy’s own published statement. Confirmed via accreditation statement provided by the pharmacy. PCAB does not currently offer a public per-pharmacy searchable database.

Has University Compounding Pharmacy had any FDA regulatory actions?

Yes, but it was resolved. In 2016, FDA inspectors found CGMP violations and production of ineligible drug products at this facility. University Compounding Pharmacy corrected it, and FDA formally confirmed the correction in 2018. Checked against FDA’s public warning-letter and closeout-letter databases.

← Back to full directorySee how we evaluate a pharmacy →